Assura Plc

JSE:AHR Stock Report

Market Cap: R28.5b

Assura Valuation

Is AHR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AHR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AHR (ZAR9.2) is trading above our estimate of fair value (ZAR3.83)

Significantly Below Fair Value: AHR is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AHR?

Key metric: As AHR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AHR. This is calculated by dividing AHR's market cap by their current earnings.
What is AHR's PE Ratio?
PE Ratio19x
EarningsUK£66.10m
Market CapUK£1.26b

Price to Earnings Ratio vs Peers

How does AHR's PE Ratio compare to its peers?

The above table shows the PE ratio for AHR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average15.6x
RDF Redefine Properties
8.1xn/aR32.1b
VKE Vukile Property Fund
12.6xn/aR20.1b
GRT Growthpoint Properties
35.1xn/aR44.5b
HYP Hyprop Investments
6.6xn/aR16.3b
AHR Assura
19x19.9%R1.3b

Price-To-Earnings vs Peers: AHR is expensive based on its Price-To-Earnings Ratio (19x) compared to the peer average (15.6x).

Price to Earnings Ratio vs Industry

How does AHR's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
AHR 19.0xIndustry Avg. 26.8xNo. of Companies5PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AHR is good value based on its Price-To-Earnings Ratio (19x) compared to the Global Health Care REITs industry average (26.8x).

Price to Earnings Ratio vs Fair Ratio

What is AHR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AHR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AHR's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AHR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentR9.20
R11.02
+19.8%
8.3%R12.54R9.12n/a9
Nov ’25n/a
R11.44
0%
6.4%R12.85R10.51n/a9
Oct ’25n/a
R11.44
0%
6.4%R12.85R10.51n/a9
Sep ’25n/a
R11.39
0%
5.8%R12.76R10.44n/a9
Aug ’25n/a
R11.47
0%
5.9%R12.65R10.35n/a9
Jul ’25n/a
R11.47
0%
5.9%R12.65R10.35n/a9
Jun ’25n/a
R11.87
0%
5.2%R13.17R10.77n/a10
May ’25n/a
R11.92
0%
4.0%R12.94R11.29n/a10
Apr ’25n/a
R12.10
0%
4.0%R13.16R11.48n/a10
Mar ’25n/a
R12.40
0%
4.3%R13.29R11.60n/a10
Feb ’25n/a
R12.32
0%
4.8%R13.29R11.60n/a10
Jan ’25n/a
R12.14
0%
6.3%R13.78R11.21n/a10
Dec ’24n/a
R12.14
0%
6.3%R13.78R11.21n/a10
Nov ’24n/a
R11.85
0%
7.1%R13.36R10.87n/a10
Oct ’24n/a
R12.47
0%
7.4%R13.74R11.18n/a9
Sep ’24n/a
R12.92
0%
6.5%R14.11R11.72n/a9
Aug ’24n/a
R12.79
0%
12.7%R17.13R11.19n/a10
Jul ’24n/a
R13.87
0%
13.9%R17.60R12.20n/a10
Jun ’24n/a
R14.64
0%
13.8%R18.27R12.67n/a10
May ’24n/a
R13.40
0%
13.7%R16.47R10.98n/a10
Apr ’24n/a
R13.40
0%
13.7%R16.47R10.98n/a10
Mar ’24n/a
R13.34
0%
12.8%R16.43R10.95n/a11
Feb ’24n/a
R13.46
0%
11.2%R15.97R11.71n/a11
Jan ’24n/a
R13.68
0%
11.7%R16.18R11.56n/a11
Dec ’23n/a
R14.19
0%
11.7%R16.58R11.84n/a11
Nov ’23n/a
R14.39
0%
11.2%R16.08R11.07n/a11

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Accelerate Property Fund

R647.9m

Accelerate Property Fund is a South African Real Estate Investment Trust (REIT) listed on the JSE Limited.

APF

R0.50

7D

-3.8%

1Y

-28.6%

Safari Investments RSA

R1.6b

SAFARI is a property investment company listed on the JSE as a Real Estate Investment Trust that specialises in quality commercial investments.

SAR

R6.25

7D

0%

1Y

13.4%

Redefine Properties

R32.1b

Redefine Properties Limited (Redefine) is a South African-based Real Estate Investment Trust (REIT).

RDF

R4.76

7D

-1.0%

1Y

39.6%